AstraZeneca turns down 'final' offer

LAST BID: Pfizer said it has made a final and improved takeover approach worth £69bn for AstraZeneca

LAST BID: Pfizer said it has made a final and improved takeover approach worth £69bn for AstraZeneca

First published in Business News

DRUGS firm AstraZeneca has rejected an improved £69bn final takeover offer from US rival Pfizer.

Pfizer had made a new offer of £55 per share.

However, AstraZeneca says the new proposal undervalues the company and its attractive prospects.

Pfizer's pursuit has gained close scrutiny over fears it would hamper AstraZeneca's drug research and cut jobs.

The US company planned to create the world's largest drug company, with its headquarters in New York, but based in the UK for tax purposes.

Send us your news, pictures and videos

Most read stories

Local Info

Enter your postcode, town or place name

About cookies

We want you to enjoy your visit to our website. That's why we use cookies to enhance your experience. By staying on our website you agree to our use of cookies. Find out more about the cookies we use.

I agree